Israeli researchers say vaccine for coronavirus could be available in three months

Officials at a northern Israeli research institute say an existing vaccine for poultry could be modified



Israeli researchers claim to have made a key breakthrough in the search for a vaccine against coronavirus, saying one could be available for use in humans within three months.

Researchers at the Galilee Scientific Research Institute (Migal) said on Thursday that they could tweak the findings of their research on developing a vaccine for coronavirus in poultry.

They said in a press conference that the virus’ similar DNA structure in humans and poultry enabled modification of the existing vaccine and could make it effective in humans, Ynet reported.

“There is a high urgency around the world to develop a vaccine for the coronavirus in humans, so we are working to expedite the development process and achieve an effective vaccine for the COVID-19 virus over the next 8-10 weeks and move to safety trials [in humans] within 90 days,” Migal CEO David Zigdon said.

He said that Migal was working with partners globally to accelerate the research process in humans needed to complete the vaccine’s development and ensure that it met required regulatory standards.

"Under these conditions, where the disease causes enormous damages as it worsens, I believe the regulations will be eased," Migal founder Professor David Levanon added.

He said that in normal conditions it might have been several more years before the vaccine would have become available for use in humans.

Israel’s Minister of Science and Technology Ofir Akunis congratulated the Migal researchers, saying: “I hope and believe there will be further progress soon.”

Migal is a research centre based in Kiryat Shmona in the Upper Galilee which specialises in biotechnology, agriculture, nutritional and environmental research. It has some 190 full-time researchers.

Meanwhile another Israeli firm, BATM, said that it had developed a testing kit for the virus to rapidly test and screen suspected coronavirus cases.

The firm said that production of the kits was underway in Rome and would facilitate the work of health officials who have warned about the reliability of existing diagnostic kits.

Share via

Want more from the JC?

To continue reading, we just need a few details...

Want more from
the JC?

To continue reading, we just
need a few details...

Get the best news and views from across the Jewish world Get subscriber-only offers from our partners Subscribe to get access to our e-paper and archive